Vaccines, blood, antisera, toxins and cultures in   Ghana

Exports In 2022, Ghana exported $255k in Vaccines, blood, antisera, toxins and cultures, making it the 122nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 263rd most exported product in Ghana. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ghana are: United States ($158k), Belgium ($52.2k), Nigeria ($13.5k), China ($5.8k), and Kenya ($5.66k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ghana between 2021 and 2022 were United States ($88.9k), Belgium ($16k), and Niger ($5.22k).

Imports In 2018, Ghana imported $114M in Vaccines, blood, antisera, toxins and cultures, becoming the 95th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 38th most imported product in Ghana. Ghana imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($35.4M), United Kingdom ($32.8M), Belgium ($19M), India ($10.4M), and France ($6.21M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ghana between 2021 and 2022 were United Kingdom ($32.6M), Japan ($1.09M), and Indonesia ($1.09M).